As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...

Topline data were announced from a phase 3 trial evaluating orforglipron in adults with T2D and inadequate glycemic control with diet and exercise alone.

Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...

Dispensations of tirzepatide and semaglutide increased significantly in recent years while the use of other glucose-lowering ...

The former CEO of the collagen company is now leading Supergut, which plays in an emerging but competitive category of ...

People with type 2 diabetes taking the highest dose of Eli Lilly’s experimental drug orfoglipron lowered their blood sugar and lost 16 pounds on average after 40 weeks.

In the December quarter, the company's management said it plans to double the firm's pen capacity over the next couple of ...

Pharmaceutical giant Eli Lilly (LLY) surged 14% last week to $840 per share following positive Phase 3 trial results for its ...

Americans spent an estimated $71.7 billion on GLP-1 drugs including Ozempic and Wegovy in 2023, a 500 percent increase from ...

It's not just talk. Americans' spending on GLP-1 drugs including Ozempic and Wegovy has skyrocketed in the last five years.

Fruitist, known for its jumbo blueberries, has surpassed $400 million in annual sales and received backing from Ray Dalio’s ...